Neutrophil extracellular traps (NETs) in ventillator induced lung injury
中性粒细胞胞外陷阱(NET)在呼吸机引起的肺损伤中的作用
基本信息
- 批准号:9502239
- 负责人:
- 金额:$ 8.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-07 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:Acute Lung InjuryAdoptive TransferAirAnti-Bacterial AgentsBacterial InfectionsCell Death ProcessChromatin FiberClinical TreatmentComplexComplicationDNADataDepositionEnzyme-Linked Immunosorbent AssayExtravasationFutureGenerationsGoalsGrantGrowthHalf-LifeHistonesHypoxemiaImmuneIn VitroInfectionInfection preventionInflammationInflammatoryInjuryInnate Immune ResponseIntensive Care UnitsInvadedLeadLifeLungLung infectionsMechanical ventilationMethodsModelingMorphologyNeutrophil ActivationNeutrophil InfiltrationOutcomePathologyPatientsPharmacologyPhysiologicalPredispositionProductionPropertyProteinsPseudomonas aeruginosaReportingRespiratory FailureRespiratory TherapyRespiratory physiologyRoleSavingsSourceSterilityTidal VolumeTimeTissuesTraumaVentilator-induced lung injuryWorkbasecytokinedesignextracellularimmunoregulationimprovedin vivolung injurymouse modelneutrophilnovelpathogenprotective effectrespiratoryresponsetherapeutic target
项目摘要
ABSTRACT
Mechanical ventilation (MV) is a life-saving therapy for respiratory failure but also leads to severe
physiological and morphological alterations in the lung, known as ventilator-induced lung injury (VILI).
Inflammation is a key component of acute lung injury (ALI), and work from our group and others has
shown that MV leads to hypoxemia, cytokine production, neutrophil recruitment, and lung injury, even
at low tidal volumes. Although neutrophils are most often associated with the pathology of VILI, our
proposed study aims to demonstrate a regulatory, tissue-reparative function of neutrophils in the
context of VILI and susceptibility to infection. Indeed, the immunomodulatory effects of MV with
regards to infection remain unknown. Preliminary data from our lab show that MV stimulates rapid
but transient neutrophil recruitment, activation and deposition of extracellular DNA in the airspaces,
termed neutrophil extracellular traps (NETs), and we found that these NETs provide protection
against infection with Pseudomonas aeruginosa. In particular, this protective effect of neutrophil
activity lasts several days after MV, at a time when neutrophils can no longer be detected in the
airspaces. Thus, we propose the novel hypothesis that MV-induced neutrophil activation and NET
deposition in the airways constitute an innate immune response to tissue damage that
counterbalances post-trauma susceptibility to infection. In Specific Aim 1, we will demonstrate
that neutrophils are the source of MV-induced NETs using depletion, adoptive transfer and PCR-
based methods to detect NET-DNA, as well as quantify the half-life of NETs in the airspaces. Despite
the known antibacterial properties of NETs and their induction in response to MV, no study has
investigated the impact of NETs on subsequent infection. Thus, in Specific Aim 2, we will
experimentally ablate NETs and NET components, both in vivo and in vitro, to determine their impact
on bacterial infection of the lung. Thus, using MV as a model of sterile ALI with transient neutrophil
extravasation into the air spaces, our work aims to identify an as-yet-unidentified protective effect of
NET production and thereby improve the design of future clinical treatments to increase lung function
and prevent infection.
摘要
机械通气(MV)是呼吸衰竭的救命疗法,但也会导致严重的呼吸衰竭。
肺的生理和形态学改变,称为呼吸机诱导的肺损伤(VILI)。
炎症是急性肺损伤(ALI)的关键组成部分,我们小组和其他人的工作已经
表明MV导致低氧血症、细胞因子产生、中性粒细胞募集和肺损伤,甚至
在低潮气量下。虽然中性粒细胞最常与VILI的病理学相关,但我们的
这项研究的目的是证明中性粒细胞的调节,组织修复功能,
VILI的背景和感染易感性。事实上,MV的免疫调节作用与
感染情况仍不清楚。我们实验室的初步数据显示,MV刺激快速
但短暂的中性粒细胞募集,细胞外DNA的激活和沉积在空气空间中,
称为中性粒细胞胞外陷阱(NET),我们发现这些NET提供保护,
对抗铜绿假单胞菌感染尤其是中性粒细胞的这种保护作用
活动持续数天后,MV,在一个时间时,中性粒细胞不能再检测到在
空域因此,我们提出了新的假设,即MV诱导的中性粒细胞活化和NET
气道中的沉积构成对组织损伤的先天免疫反应,
平衡创伤后感染的易感性。在具体目标1中,我们将展示
中性粒细胞是MV诱导的NET的来源,使用耗竭,过继转移和PCR-
基于检测NET-DNA的方法,以及量化空气空间中NET的半衰期。尽管
NET的已知抗菌特性及其对MV的诱导,没有研究
研究NET对后续感染的影响。因此,在具体目标2中,我们
在体内和体外实验性消融NET和NET组件,以确定其影响
关于肺部细菌感染因此,使用MV作为无菌性ALI伴一过性中性粒细胞减少的模型,
外渗到空气空间,我们的工作旨在确定一个尚未确定的保护作用,
NET生产,从而改善未来临床治疗的设计,以增加肺功能
防止感染
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Heather Jones其他文献
Heather Jones的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Heather Jones', 18)}}的其他基金
A High Throughput Method to Determine the Target of T Cell Receptors
一种确定 T 细胞受体靶标的高通量方法
- 批准号:
10214540 - 财政年份:2020
- 资助金额:
$ 8.75万 - 项目类别:
A High Throughput Method to Determine the Target of T Cell Receptors
一种确定 T 细胞受体靶标的高通量方法
- 批准号:
10065125 - 财政年份:2020
- 资助金额:
$ 8.75万 - 项目类别:
IL-1beta in the Development of Hypoxemia in Acute Lung Injury
IL-1β 在急性肺损伤低氧血症发展中的作用
- 批准号:
8805246 - 财政年份:2014
- 资助金额:
$ 8.75万 - 项目类别:
IL-1beta in the Development of Hypoxemia in Acute Lung Injury
IL-1β 在急性肺损伤低氧血症发展中的作用
- 批准号:
9185339 - 财政年份:2014
- 资助金额:
$ 8.75万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 8.75万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 8.75万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 8.75万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 8.75万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 8.75万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 8.75万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 8.75万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 8.75万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 8.75万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 8.75万 - 项目类别:














{{item.name}}会员




